Supplementary Data S13 from Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen-receptor pathway inhibitors

Naoual Menssouri; Loïc Poiraudeau; Carole Hélissey; Ludovic Bigot; Jonathan Sabio; Tony Ibrahim; Cédric Pobel; Claudio Nicotra; Maud Ngo‐Camus; Ludovic Lacroix; Étienne Rouleau; Lambros Tselikas; Anne Chauchereau; Félix Blanc‐Durand; Alice Bernard‐Tessier; Anna Patrikidou; Natacha Naoun; Ronan Flippot; Émeline Colomba; Alina Fuerea; Laurence Albigès; Pernelle Lavaud; Paul van de Wiel; Eveline den Biezen; Yvonne Wesseling-Rozendaal; Santiago Ponce-Aix; Stefan Michiels; Christophe Massard; Daniel Gautheret; Fabrice Barlési; Fabrice André; Benjamin Besse; Jean–Yves Scoazec; Luc Friboulet; Karim Fizazi; Yohann Loriot

doi:10.1158/1078-0432.27032461

Abstract

Supplementary data 13 describes the GSEA analysis of resistant samples vs baseline samples from patients with acquired resistance and neuroendocrine features

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Menssouri et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db6435875227ce https://doi.org/10.1158/1078-0432.27032461

View Full Paper

Ask AI

Bookmark

Share

Supplementary Data S13 from Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen-receptor pathway inhibitors

Abstract

Discussion

Cite This Study

Supplementary Data S13 from Genomic profiling of metastatic castration-resistant prostate cancer samples resistant to androgen-receptor pathway inhibitors

Abstract

Discussion

Cite This Study

Keep reading

Keep reading